ERBB2 and breast cancer: ERBB2 is found to be amplified in a number of tumor types of epithelial origin including lung, gastric and bladder cancers [3] and is a major cause of breast cancers, accounting for 15% of cases [4] where amplification drives aggressive and invasive tumor formation.